Kusurinomadoguchi Inc is engaged in providing solutions for pharmacies and medical care..
2004
320
LTM Revenue $73.2M
Last FY EBITDA $19.4M
$275M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of September 2025, Kusurinomadoguchi reported last 12-month revenue of $73.2M.
In the same period, Kusurinomadoguchi achieved $13.3M in LTM net income.
See Kusurinomadoguchi valuation multiples based on analyst estimatesIn the most recent fiscal year, Kusurinomadoguchi reported revenue of $73.2M and EBITDA of $19.4M.
Kusurinomadoguchi expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Kusurinomadoguchi valuation multiples based on analyst estimatesLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue | $73.2M | XXX | $73.2M | XXX | XXX | XXX |
Gross Profit | n/a | XXX | $42.3M | XXX | XXX | XXX |
Gross Margin | n/a | XXX | 58% | XXX | XXX | XXX |
EBITDA | n/a | XXX | $19.4M | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | 27% | XXX | XXX | XXX |
EBIT | $12.8M | XXX | $12.8M | XXX | XXX | XXX |
EBIT Margin | 17% | XXX | 17% | XXX | XXX | XXX |
Net Profit | $13.3M | XXX | $13.3M | XXX | XXX | XXX |
Net Margin | 18% | XXX | 18% | XXX | XXX | XXX |
Net Debt | XXX | XXX | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Kusurinomadoguchi has current market cap of JPY 44.1B (or $288M), and EV of JPY 42.0B (or $275M).
As of October 13, 2025, Kusurinomadoguchi's stock price is JPY 3930 (or $26).
See Kusurinomadoguchi trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$275M | $288M | XXX | XXX | XXX | XXX | $1.21 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialKusurinomadoguchi's trades at 4.0x EV/Revenue multiple, and 14.9x EV/EBITDA.
See valuation multiples for Kusurinomadoguchi and 15K+ public compsAs of October 13, 2025, Kusurinomadoguchi has market cap of $288M and EV of $275M.
Equity research analysts estimate Kusurinomadoguchi's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Kusurinomadoguchi has a P/E ratio of 21.7x.
LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Market cap (current) | $288M | XXX | $288M | XXX | XXX | XXX |
EV (current) | $275M | XXX | $275M | XXX | XXX | XXX |
EV/Revenue | 3.8x | XXX | 4.0x | XXX | XXX | XXX |
EV/EBITDA | n/a | XXX | 14.9x | XXX | XXX | XXX |
EV/EBIT | 21.5x | XXX | 23.2x | XXX | XXX | XXX |
EV/Gross Profit | n/a | XXX | n/a | XXX | XXX | XXX |
P/E | 21.7x | XXX | 25.3x | XXX | XXX | XXX |
EV/FCF | n/a | XXX | -8.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialKusurinomadoguchi's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Kusurinomadoguchi's rule of 40 is unknown (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Kusurinomadoguchi's rule of X is unknown (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Kusurinomadoguchi and other 15K+ public compsLTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
---|---|---|---|---|---|---|
Revenue Growth | n/a | XXX | n/a | XXX | XXX | XXX |
EBITDA Margin | n/a | XXX | 27% | XXX | XXX | XXX |
EBITDA Growth | n/a | XXX | n/a | XXX | XXX | XXX |
Rule of 40 | n/a | XXX | n/a | XXX | XXX | XXX |
Bessemer Rule of X | XXX | XXX | n/a | XXX | XXX | XXX |
Revenue per Employee | XXX | XXX | $0.2M | XXX | XXX | XXX |
Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
R&D Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
Opex to Revenue | XXX | XXX | 40% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Apiam Animal Health | XXX | XXX | XXX | XXX | XXX | XXX |
Alcidion Group | XXX | XXX | XXX | XXX | XXX | XXX |
Artrya | XXX | XXX | XXX | XXX | XXX | XXX |
CurveBeam AI | XXX | XXX | XXX | XXX | XXX | XXX |
Doctor Care Anywhere | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Kusurinomadoguchi acquired XXX companies to date.
Last acquisition by Kusurinomadoguchi was XXXXXXXX, XXXXX XXXXX XXXXXX . Kusurinomadoguchi acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free TrialWhen was Kusurinomadoguchi founded? | Kusurinomadoguchi was founded in 2004. |
Where is Kusurinomadoguchi headquartered? | Kusurinomadoguchi is headquartered in Japan. |
How many employees does Kusurinomadoguchi have? | As of today, Kusurinomadoguchi has 320 employees. |
Is Kusurinomadoguchi publicy listed? | Yes, Kusurinomadoguchi is a public company listed on TKS. |
What is the stock symbol of Kusurinomadoguchi? | Kusurinomadoguchi trades under 5592 ticker. |
When did Kusurinomadoguchi go public? | Kusurinomadoguchi went public in 2023. |
Who are competitors of Kusurinomadoguchi? | Similar companies to Kusurinomadoguchi include e.g. Apiam Animal Health, Alcidion Group, Artrya, CurveBeam AI. |
What is the current market cap of Kusurinomadoguchi? | Kusurinomadoguchi's current market cap is $288M |
What is the current revenue of Kusurinomadoguchi? | Kusurinomadoguchi's last 12 months revenue is $73.2M. |
What is the current EV/Revenue multiple of Kusurinomadoguchi? | Current revenue multiple of Kusurinomadoguchi is 3.8x. |
Is Kusurinomadoguchi profitable? | Yes, Kusurinomadoguchi is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.